References

National Head and Neck Cancer Audit. 2011;
Improving Outcomes in Head and Neck Cancer. 2004;
Diagnosis and Management of Head and Neck Cancer. 2006;
Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J, Pignon JP MACH-CH Collaborative group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol. 2011; 100:(1)33-40
Nutting CM, Morden JP, Harrington KJ Parotid-sparing intensity modulated radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomized controlled trial. Lancet Oncology. 2011; 12:(2)127-136
Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; 100:261-269
Porter SR, Fedele S, Habbab KM. Xerostomia in head and neck malignancy. Oral Oncol. 2010; 46:(6)460-463
Scott B, Butterworth C, Lowe D, Rogers SN. Factors associated with restricted mouth opening and its relationship to health-related quality of life in patients attending a Maxillofacial Oncology clinic. Oral Oncol. 2008; 44:(5)430-438
Bese NS, Hendry J, Jeremic B. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys. 2007; 68:(3)654-661
Lyons AJ, West CM, Risk JM Osteoradionecrosis in head and neck cancer has a distinct genotype-dependent cause. Int J Radiat Oncol Biol Phys. 2011; 25
Epstein JB, Silverman S, Paggiarino DA, Crockett S, Schubert MM, Senzer NN Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomised, double-blind, placebo controlled clinical trial. Cancer. 2001; 92:(4)875-885
Bondestan O, Gahnberg L. Effect of chlorhexidine gel on the prevalence of mutans streptococci and lactobacilli. Spec Care Dent. 1996; 16:123-128
Strietzel FP, Martin-Granzio R, Fedele S Electrostimulating device in the management of xerostomia. Oral Dis. 2007; 13:(2)206-213

Oral and dental management for head and neck cancer patients treated by chemotherapy and radiotherapy

From Volume 39, Issue 2, March 2012 | Pages 135-140

Authors

Lorna K McCaul

BDS, FDS RCPS(Glasg), MRD, RCS(Edin) FDS(Rest Dent)

Consultant in Restorative Dentistry and Oral Rehabilitation, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK

Articles by Lorna K McCaul

Abstract

The incidence of head and neck cancer is rising. The attendant oral complications of cancer management make oral health maintenance a lifelong challenge for these patients. Holistic management in the context of a core multidisciplinary team is essential in optimizing outcomes. Predicting the risk of adverse oral outcomes is difficult. Effective communication between healthcare professionals in the core and extended teams and with the patient is essential.

Clinical Relevance: Primary care dental teams will be involved in the long-term management of oral care for head and cancer patients. A broad understanding of the management of head and neck cancer, consequences of treatment and the need for good communication is key to good quality patient care.

Article

Cancers of the head and neck include those of the oral cavity, oropharynx, salivary glands, sinuses, nasopharynx, hypopharynx and larynx. There are approximately 6,700 new head and neck cancers diagnosed each year in England and Wales and approximately 1,100 in Scotland. Eighty-five percent of cases are in people aged over 50 years, however, there is evidence of increasing incidence in younger people.1,2,3 There has been a more than 30% increase in oral cavity cancer between 1990 and 2006 and the incidence of oropharyngeal cancer has more than doubled.1 There may be a change in the pattern of aetiology of oropharyngeal cancer, with human papilloma virus (HPV) rather than smoking and alcohol being the primary risk factor in a younger sub-population. Ninety percent of patients presenting with head and neck cancer have pre-existing dental disease. Many also have co-morbidities. These factors, together with the increasing retention of teeth into old age, result in significant challenges in the management of the oral and dental health for these patients.

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available